High dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II study

Trial Profile

High dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II study

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2012

At a glance

  • Drugs Simvastatin (Primary) ; Dexamethasone; Doxorubicin; Vincristine
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Sep 2009 Status changed from active, no longer recruiting to discontinued as reported by Netherlands Trials Register record.
    • 14 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top